<p>上周，您可能看到 <strong>新秀丽集团 S.A.</strong> (HKG:1910) 向市场发布了其季度业绩。早期反应并不积极，过去一周股价下跌了 3.9%，至 14.61 港元。整体业绩表现不佳，每股收益为 0.023 美元，远低于分析师的预期。同时，收入达到 8.29 亿美元，略好于预测。收益是投资者关注的重要时刻，因为他们可以跟踪公司的表现，查看分析师对明年的预测，并观察对公司的情绪是否发生变化。因此，我们收集了最新的财报后预测，以了解估计对明年的展望。</p>
<p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
<p>根据最新的业绩，13 位分析师现在预测新秀丽集团在 2026 年的收入为 36 亿美元。这将比过去 12 个月的收入提高 2.1%。法定每股收益预计将上升 3.4%，达到 0.20 美元。然而，在最新业绩之前，分析师们曾预计 2026 年的收入为 35.6 亿美元，每股收益（EPS）为 0.21 美元。因此，似乎在最近的业绩发布后，整体情绪略有下降——收入预期没有重大变化，但分析师确实对每股收益的预测进行了小幅下调。</p>
<p>查看我们对新秀丽集团的最新分析</p>
<p>可能令人惊讶的是，分析师的共识目标价下降了 5.5%，至 21.86 港元，分析师显然将较低的预测收益与股价表现联系在一起。然而，这并不是我们可以从这些数据中得出的唯一结论，因为一些投资者在评估分析师的目标价时也喜欢考虑估计值的差异。最乐观的新秀丽集团分析师的目标价为每股 26.11 港元，而最悲观的则为 16.80 港元。因此，在这种情况下，我们不会对分析师的目标价给予过多信任，因为显然对这家企业的表现存在广泛的不同看法。考虑到这一点，我们不应过于依赖共识目标价，因为这只是一个平均值，分析师显然对这家企业有着截然不同的看法。</p>
<p>现在从更大的视角来看，我们可以通过将这些预测与过去的表现和行业增长预期进行比较来理解它们。我们要强调的是，新秀丽集团的收入增长预计将放缓，预计到 2026 年底的年化增长率为 2.8%，远低于过去五年的 15% 的历史增长率。相比之下，该行业其他受到分析师覆盖的公司预计年收入增长为 8.4%。因此，很明显，尽管预计收入增长将放缓，但整个行业的增长速度也预计将快于新秀丽集团。</p>
<h2>结论</h2>
<p>最大的担忧是分析师下调了每股收益的预期，这表明新秀丽集团可能面临业务逆风。幸运的是，分析师们也重新确认了他们的收入预期，表明其与预期一致。尽管我们的数据确实表明，新秀丽集团的收入预计将表现不及整个行业。共识目标价显著下降，分析师们似乎对最新的业绩并不感到安慰，导致对新秀丽集团未来估值的预期降低。</p>
<p>话虽如此，公司的长期收益轨迹远比明年更为重要。在 Simply Wall St，我们有新秀丽集团到 2028 年的全系列分析师估计，您可以在我们的平台上免费查看。</p>
<p>此外，您还应该了解我们发现的 <strong>2 个警告信号</strong> 与新秀丽集团有关。</p>

新秀丽(ADR)

新秀丽

<p>新秀丽集团（Samsonite Group S.A.）公布了令人失望的季度业绩，每股收益为 0.023 美元，低于分析师预期 32%。尽管收入为 8.29 亿美元略微超过预测，但股价下跌 3.9%，至 14.61 港元。分析师现在预测 2026 年收入为 36 亿美元，增长 2.1%，但每股收益预期被下调至 0.20 美元。共识目标价下调 5.5%，至 21.86 港元，反映出对未来收益的担忧，因为收入增长速度较行业同行放缓</p>

<p>Last week, you might have seen that <strong>Samsonite Group S.A.</strong> (HKG:1910) released its quarterly result to the market. The early response was not positive, with shares down 3.9% to HK$14.61 in the past week. Results overall were not great, with earnings of US$0.023 per share falling drastically short of analyst expectations. Meanwhile revenues hit US$829m and were slightly better than forecasts. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.</p>
<div class="lb-trans"><p>上周，您可能看到 <strong>新秀丽集团 S.A.</strong> (HKG:1910) 向市场发布了其季度业绩。早期反应并不积极，过去一周股价下跌了 3.9%，至 14.61 港元。整体业绩表现不佳，每股收益为 0.023 美元，远低于分析师的预期。同时，收入达到 8.29 亿美元，略好于预测。收益是投资者关注的重要时刻，因为他们可以跟踪公司的表现，查看分析师对明年的预测，并观察对公司的情绪是否发生变化。因此，我们收集了最新的财报后预测，以了解估计对明年的展望。</p>
</div><p>AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.</p>
<div class="lb-trans"><p>人工智能即将改变医疗保健。这 20 只股票正在从早期诊断到药物发现等各个方面进行工作。最棒的是——它们的市值都在 100 亿美元以下——现在仍然有机会提前布局。</p>
</div><p>Following the latest results, Samsonite Group's 13 analysts are now forecasting revenues of US$3.60b in 2026. This would be a satisfactory 2.1% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to rise 3.4% to US$0.20. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$3.56b and earnings per share (EPS) of US$0.21 in 2026. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a minor downgrade to their earnings per share forecasts.</p>
<div class="lb-trans"><p>根据最新的业绩，13 位分析师现在预测新秀丽集团在 2026 年的收入为 36 亿美元。这将比过去 12 个月的收入提高 2.1%。法定每股收益预计将上升 3.4%，达到 0.20 美元。然而，在最新业绩之前，分析师们曾预计 2026 年的收入为 35.6 亿美元，每股收益（EPS）为 0.21 美元。因此，似乎在最近的业绩发布后，整体情绪略有下降——收入预期没有重大变化，但分析师确实对每股收益的预测进行了小幅下调。</p>
</div><p>Check out our latest analysis for Samsonite Group</p>
<div class="lb-trans"><p>查看我们对新秀丽集团的最新分析</p>
</div><p>It might be a surprise to learn that the consensus price target fell 5.5% to HK$21.86, with the analysts clearly linking lower forecast earnings to the performance of the stock price. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic Samsonite Group analyst has a price target of HK$26.11 per share, while the most pessimistic values it at HK$16.80. So we wouldn't be assigning too much credibility to analyst price targets in this case, because there are clearly some widely different views on what kind of performance this business can generate. With this in mind, we wouldn't rely too heavily the consensus price target, as it is just an average and analysts clearly have some deeply divergent views on the business.</p>
<div class="lb-trans"><p>可能令人惊讶的是，分析师的共识目标价下降了 5.5%，至 21.86 港元，分析师显然将较低的预测收益与股价表现联系在一起。然而，这并不是我们可以从这些数据中得出的唯一结论，因为一些投资者在评估分析师的目标价时也喜欢考虑估计值的差异。最乐观的新秀丽集团分析师的目标价为每股 26.11 港元，而最悲观的则为 16.80 港元。因此，在这种情况下，我们不会对分析师的目标价给予过多信任，因为显然对这家企业的表现存在广泛的不同看法。考虑到这一点，我们不应过于依赖共识目标价，因为这只是一个平均值，分析师显然对这家企业有着截然不同的看法。</p>
</div><p>Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. We would highlight that Samsonite Group's revenue growth is expected to slow, with the forecast 2.8% annualised growth rate until the end of 2026 being well below the historical 15% p.a. growth over the last five years. By way of comparison, the other companies in this industry with analyst coverage are forecast to grow their revenue at 8.4% per year. So it's pretty clear that, while revenue growth is expected to slow down, the wider industry is also expected to grow faster than Samsonite Group.</p>
<div class="lb-trans"><p>现在从更大的视角来看，我们可以通过将这些预测与过去的表现和行业增长预期进行比较来理解它们。我们要强调的是，新秀丽集团的收入增长预计将放缓，预计到 2026 年底的年化增长率为 2.8%，远低于过去五年的 15% 的历史增长率。相比之下，该行业其他受到分析师覆盖的公司预计年收入增长为 8.4%。因此，很明显，尽管预计收入增长将放缓，但整个行业的增长速度也预计将快于新秀丽集团。</p>
</div><h2>The Bottom Line</h2>
<div class="lb-trans"><h2>结论</h2>
</div><p>The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Samsonite Group. Fortunately, the analysts also reconfirmed their revenue estimates, suggesting that it's tracking in line with expectations. Although our data does suggest that Samsonite Group's revenue is expected to perform worse than the wider industry. The consensus price target fell measurably, with the analysts seemingly not reassured by the latest results, leading to a lower estimate of Samsonite Group's future valuation.</p>
<div class="lb-trans"><p>最大的担忧是分析师下调了每股收益的预期，这表明新秀丽集团可能面临业务逆风。幸运的是，分析师们也重新确认了他们的收入预期，表明其与预期一致。尽管我们的数据确实表明，新秀丽集团的收入预计将表现不及整个行业。共识目标价显著下降，分析师们似乎对最新的业绩并不感到安慰，导致对新秀丽集团未来估值的预期降低。</p>
</div><p>With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At Simply Wall St, we have a full range of analyst estimates for Samsonite Group going out to 2028, and you can see them free on our platform here..</p>
<div class="lb-trans"><p>话虽如此，公司的长期收益轨迹远比明年更为重要。在 Simply Wall St，我们有新秀丽集团到 2028 年的全系列分析师估计，您可以在我们的平台上免费查看。</p>
</div><p>Plus, you should also learn about the <strong>2 warning signs</strong> we've spotted with Samsonite Group .</p>
<div class="lb-trans"><p>此外，您还应该了解我们发现的 <strong>2 个警告信号</strong> 与新秀丽集团有关。</p>
</div>

新秀丽集团 S.A.的每股收益刚刚低于预期 32%：分析师认为接下来会发生什么